These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697 [TBL] [Abstract][Full Text] [Related]
3. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators. Swerdlow CD; Ahern T; Kass RM; Davie S; Mandel WJ; Chen PS J Am Coll Cardiol; 1996 Apr; 27(5):1112-8. PubMed ID: 8609329 [TBL] [Abstract][Full Text] [Related]
4. Transthoracic defibrillation of short-lasting ventricular fibrillation: a randomised trial for comparison of the efficacy of low-energy biphasic rectilinear and monophasic damped sine shocks. Szili-Torok T; Theuns D; Verblaauw T; Scholten M; Kimman GJ; Res J; Jordaens L Acta Cardiol; 2002 Oct; 57(5):329-34. PubMed ID: 12405569 [TBL] [Abstract][Full Text] [Related]
6. Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs. Swerdlow CD; Shehata M; Chen PS Pacing Clin Electrophysiol; 2007 Feb; 30(2):258-70. PubMed ID: 17338725 [TBL] [Abstract][Full Text] [Related]
7. Energy levels for defibrillation: what is of real clinical importance? Fotuhi PC; Epstein AE; Ideker RE Am J Cardiol; 1999 Mar; 83(5B):24D-33D. PubMed ID: 10089836 [TBL] [Abstract][Full Text] [Related]
8. Truncated biphasic pulses for transthoracic defibrillation. Bardy GH; Gliner BE; Kudenchuk PJ; Poole JE; Dolack GL; Jones GK; Anderson J; Troutman C; Johnson G Circulation; 1995 Mar; 91(6):1768-74. PubMed ID: 7882486 [TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of the effect of biphasic waveform defibrillation on ventricular pacing thresholds. Kudenchuk PJ; Poole JE; Dolack GL; Gleva MJ; Anderson J; Troutman C; Bardy GH J Cardiovasc Electrophysiol; 1997 May; 8(5):485-95. PubMed ID: 9160224 [TBL] [Abstract][Full Text] [Related]
12. Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing should not be routinely performed at the time of implantable cardioverter defibrillator implantation. Healey JS; Brambatti M Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):347-51. PubMed ID: 24736424 [No Abstract] [Full Text] [Related]
13. [Safety and efficacy of intraoperative defibrillation threshold measured by defibrillation safety margin in 52 patients with implantable cardioverter defibrillator]. Zhang Y; Yuan KD; Tang BP; Ma YT; Zhang YY; Wang J; Li JX; Zhang JH; Xu GJ Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Nov; 38(11):975-8. PubMed ID: 21215224 [TBL] [Abstract][Full Text] [Related]
14. Defibrillation energy requirements using a left anterior chest cutaneous to subcutaneous shocking vector: implications for a total subcutaneous implantable defibrillator. Burke MC; Coman JA; Cates AW; Lindstrom CC; Sandler DA; Kim SS; Knight BP Heart Rhythm; 2005 Dec; 2(12):1332-8. PubMed ID: 16360086 [TBL] [Abstract][Full Text] [Related]
15. Estimating the 95% effective defibrillation dose. Malkin RA; Burdick DS; Johnson EE; Pilkington TC; Swanson DK; Ideker RE IEEE Trans Biomed Eng; 1993 Mar; 40(3):256-65. PubMed ID: 8335329 [TBL] [Abstract][Full Text] [Related]
16. The role of defibrillation testing. Amit G; Healey JS Card Electrophysiol Clin; 2015 Sep; 7(3):539-46. PubMed ID: 26304533 [TBL] [Abstract][Full Text] [Related]
17. Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing is necessary at the time of implantable cardioverter defibrillator implantation. Russo AM; Chung MK Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):337-46. PubMed ID: 24736423 [No Abstract] [Full Text] [Related]